A Study of LY3484356 in Healthy Female Participants
Status:
Recruiting
Trial end date:
2021-12-28
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the amount of LY3484356 is found in the blood
stream and how long the body takes to get rid of it when given with and without food, in
healthy females participants of non-childbearing potential. The study will also evaluate the
tolerability and safety of LY3484356 by collecting the information about any side effects
that may occur. The study will last approximately 27 days, not including screening.